Shield Therapeutics plc (AIM:STX)

Shield Therapeutics Revenue

Shield Therapeutics had revenue of $30.37M USD in the half year ending June 30, 2026, with 150.34% growth. This brings the company's revenue in the last twelve months to $58.63M, up 41.28% year-over-year. In the year 2025, Shield Therapeutics had annual revenue of $49.70M with 54.45% growth.

• Revenue (ttm): $58.63M
• Revenue Growth: +41.28%
• P/S Ratio: 1.13
• Revenue / Employee: $961.07K
• Employees: 61
• Market Cap: 49.86M GBP

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	49.70M	17.52M	54.45%
Dec 31, 2024	32.18M	19.10M	145.93%
Dec 31, 2023	13.09M	7.59M	137.95%
Dec 31, 2022	5.50M	3.45M	167.76%
Dec 31, 2021	2.05M	-12.15M	-85.54%
Dec 31, 2020	14.20M	13.25M	1,389.43%
Dec 31, 2019	953.46K	-14.18M	-93.70%
Dec 31, 2018	15.13M	14.27M	1,657.92%
Dec 31, 2017	860.83K	485.65K	129.44%
Dec 31, 2016	375.19K	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-

Data Source: Fiscal.ai Last updated: Aug 21, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 8, 2026

Data Sources Report a data error